Z-2622-2024 Class III Ongoing

Recalled by DRG International, Inc. — Springfield, NJ

FDA device recall Z-2622-2024 was initiated by DRG International, Inc. on Jul 5, 2024 and is designated Class III. Reason for recall: Invalid Controls. The Low Control is out of range; too high which causes invalid runs that would result in repeating the runs and delays for reporting results to patients. The recall status is ongoing. Affected quantity: 257 units.

Recall details

Product Type
Devices
Report Date
Aug 21, 2024
Initiation Date
Jul 5, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
257 units

Product description

Product Name: Salivary Testosterone ELISA Model/Catalog Number: SLV-3013 Product Description: An enzyme immunoassay for the quantitative in vitro diagnostic measurement of free active testosterone in saliva.

Reason for recall

Invalid Controls. The Low Control is out of range; too high which causes invalid runs that would result in repeating the runs and delays for reporting results to patients.

Distribution pattern

US Nationwide distribution in the states of CA, IL, MN, PA, UT, VA.

Code information

Model/Catalog Number: SLV-3013; UDI-DI: 04048474030136; Lot Nymbers: 66K014 and 66K123.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2622-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2622-2024. Report a data issue: hello@regdatalab.com.